MedPath

To study The Efficacy Of Durvadi Lepa And Abhayaristadi Churna On Vicharchika.

Not Applicable
Conditions
Health Condition 1: L278- Dermatitis due to other substancestaken internally
Registration Number
CTRI/2023/02/049415
Lead Sponsor
arayan Sahu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of both sexes in between 12-60 yrs of age with classical signs and symptoms like Kandu, Pidaka, Shyva, Bahusrava of Vicharchika will be included in study.

Eczema infections as per modern science Atopic dermatitis, Contact dermatitis, Dyshidrotic eczema, Neurodermatitis, Nummular eczema, Stasis dermatitis will be included in this study.

 

Exclusion Criteria

Patients with systemic disorder like Hypertension, Diabetes mellitus, leprosy, anemia, any carcinogenic disorder, HIV positive patients.

Patients having signs & symptoms of other skin disorder like TB skin, scabies, Eczema etc.

Pregnant woman & lactating mother.

Patients who have undergone recent surgeries.

Patients taking immunosuppressive medicines.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To decrease the sign symptoms of Vicharchika like Kandu (Excessive itching), Pidaka (Eruption), Shyava (Erythma with discolouration), Bahusrava (Profuse discharge, oozing), Rajji (Thickening of skin), Arti( Pain), Rukshya ( Dry lesion) <br/ ><br>Timepoint: 1. DC, TLC, ESR, FBS, IgE will be assesed in every 07days for 01 month.
Secondary Outcome Measures
NameTimeMethod
Durvadi lepa may be more effective than Abhayaristadi ChurnaTimepoint: 30 days;Durvadi Lepa may be more effective than Abhayaristadi Churna individually.Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath